Keyword : tyrosine kinase inhibitors
Personalized target therapy of locally advanced and mrcc: from retrospective studies to implementation in clinical practiceAuthors: Chekhun V. Stakhovsky E. Vitruk Iu. Lukianova N.... Дата: 2024-11-01
Efficacy of EGFR TKIs of different generations in NSCLC with EGFR mutations: review of clinical studies and our experienceAuthors: Kobziev O.I. Boiarskyi O.O. Leonova V.V. Т. 12, № 3-4 (47-48)
Prevalence of EGFR gene mutations in Ukrainian patients with locally advanced or metastatic non-small cell lung cancer
Authors: Shparyk Ya.V. Ponomareva O.V. Sokolov V.V. Kobzev O.Y.... T. 10, № 1-2 (37-38)
Authors: Shparyk Ya.V. Ponomareva O.V. Sokolov V.V. Kobzev O.Y.... T. 10, № 1-2 (37-38)
The role of targeted therapy in the treatment of patients with EGFR+ mutations of lung cancer (review)Authors: Kolesnik O.P. Shevchenco A.I. Kadzhoian A.V. Kuzmenko V.A.... Т. 8, № 3 (31) 2018
The role of neoadjuvant and adjuvant chemotherapy in the treatment of patients with lung cancer (review)Authors: Kolesnik O.P. Shevchenco A.I. Kadzhoian A.V. Kuzmenko V.A.... Т. 8, № 2 (30) 2018
